計算生物学の世界市場レポート 2025年

計算生物学の市場規模は、今後数年で飛躍的な成長が見込まれます。2029年にはCAGR23.9％で224億7,000万米ドルに成長します。予測期間の成長は、クラウドコンピューティングとハイパフォーマンスコンピューティング（HPC）、定量生物学と予測生物学の採用、学際的共同研究、バイオインフォマティクスと計算ツールの進歩に起因しています。予測期間における主な動向としては、データサイエンスとバイオインフォマティクスの進歩、ゲノムシーケンス技術、バイオインフォマティクスにおける機械学習とAI、創薬と薬剤開発、個別化医療と精密ヘルスケアなどが挙げられます。

政府の資金援助が計算生物学市場の主な促進要因となっています。世界中の政府が、研究開発、教育機関、その他の分野における計算生物学の能力を向上させるために、インフラや学術コースに資金を提供しています。研究開発、臨床研究、その他の開発活動で広く利用されている計算生物学的ソリューションは、政府からの資金提供の急増によって需要が高まると期待されています。例えば、2023年4月、米国の政府機関である国立がん研究所（NCI）によると、2021会計年度、NCIの総予算は64億米ドルで、これにはCURES法からの資金1億9,500万米ドルが含まれています。これは前年度比1.6％増で、9,930万米ドルの増加となります。したがって、政府からの資金援助が計算生物学市場の成長を牽引しています。

個別化医療に対する需要の高まりは、計算生物学の今後の成長を促進すると予想されます。個別化医療は精密医療とも呼ばれ、患者の治療計画を立てる際に遺伝子、環境、ライフスタイルの個人差を考慮する治療とヘルスケアへのアプローチです。個別化医療は、個人の遺伝子データを分析し、オーダーメイドの治療を行います。計算生物学は、この遺伝子情報を解析し、標的療法の開発、治療レジメンの最適化、治療結果の予測を可能にする重要な役割を担っています。患者を特定のサブグループに層別化し、ヘルスケアコストを削減し、規制や臨床ガイドラインに沿うことができます。例えば、米国を拠点とする専門家会員組織である個別化医療連合（Personalized Medicine Coalition）によると、2022年に食品医薬品局（Food and Drug Administration）の医薬品評価研究センター（Center for Drug Evaluation and Research：CDER）は37件の新規分子化合物（NME）を承認しました。35件の治療用NMEのうち、約34％にあたる12件が、個別化医療連合（PMC）によって個別化医薬品に分類されました。したがって、個別化医療に対する需要の高まりが計算生物学市場の成長を牽引しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の計算生物学市場のPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の計算生物学市場の成長率分析
• 世界の計算生物学市場の実績：規模と成長、2019～2024年
• 世界の計算生物学市場の予測：規模と成長、2024～2029年、2034年
• 世界の計算生物学総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の計算生物学市場：サービス別、実績と予測、2019～2024年、2024～2029年、2034年
• 社内
• 契約
• 世界の計算生物学市場：ツール別、実績と予測、2019～2024年、2024～2029年、2034年
• データベース
• インフラ（ハードウェア）
• 分析ソフトウェアとサービス
• 世界の計算生物学市場：用途別、実績と予測、2019～2024年、2024～2029年、2034年
• 細胞および生物学シミュレーション
• 創薬と疾患モデル化
• 臨床試験
• 世界の計算生物学市場：エンドユーザー別、実績と予測、2019～2024年、2024～2029年、2034年
• 研究
• 製薬業界
• 商業用途
• 世界の計算生物学市場：社内のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• データ分析
• ソフトウェア開発
• 研究開発
• 世界の計算生物学市場：契約のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• バイオインフォマティクスの外部委託
• 共同研究
• データ管理サービス

第7章 地域別・国別分析

• 世界の計算生物学市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界の計算生物学市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 計算生物学市場：競合情勢
• 計算生物学市場：企業プロファイル
  • Certara L. P Overview, Products and Services, Strategy and Financial Analysis
  • Chemical Computing Group Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Compugen Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Genedata AG Overview, Products and Services, Strategy and Financial Analysis
  • Insilico Biotechnology AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Dassault Systemes SE
• Instem PLC
• Rosa & Co. LLC
• Simulation Plus Inc.
• Nimbus Discovery LLC
• Rhenovia Pharma SAS
• Leadscope Inc.
• DNAnexus
• Altaris Capital Partner
• Genialis Inc.
• Inari Agriculture Inc.
• BC Platforms
• Ventus Therapeutics
• Monte Rosa Therapeutics
• Schrodinger Inc.

第32章 世界市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 市場の最近の動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 計算生物学市場2029年-最も新しい機会を提供する国
• 計算生物学市場2029年-最も新しい機会を提供するセグメント
• 計算生物学市場2029年-成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Computational biology refers to the field of science that teaches students how to use computer science, statistics, and mathematics to solve biological problems. A wide range of biological disciplines, including genomics/genetics, biophysics, cell biology, biochemistry, and evolution, are included in computational biology.

The main types of computational biology are in-house and contract. The in-house market consists of sales of computational biological solutions that are performed within a company. The firm uses its own employees and time to perform a business activity, such as financing or brokering. The various tools applied are databases, infrastructure (hardware), and analysis software and services that are used in applications such as cellular and biological simulation, drug discovery and disease modelling, and clinical trials. The industries that have adopted computational biology are research, the pharmaceutical industry, and commercial applications.

The computational biology market research report is one of a series of new reports from The Business Research Company that provides computational biology market statistics, including computational biology industry global market size, regional shares, competitors with a computational biology market share, detailed computational biology market segments, market trends and opportunities, and any further data you may need to thrive in the computational biology industry. This computational biology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The computational biology market size has grown rapidly in recent years. It will grow from $8.09 billion in 2024 to $9.52 billion in 2025 at a compound annual growth rate (CAGR) of 17.6%. The growth in the historic period can be attributed to multi-omics integration, personalized medicine and precision healthcare, genomic sequencing revolution, handling biological big data.

The computational biology market size is expected to see exponential growth in the next few years. It will grow to $22.47 billion in 2029 at a compound annual growth rate (CAGR) of 23.9%. The growth in the forecast period can be attributed to cloud computing and high-performance computing (HPC), quantitative and predictive biology adoption, collaborative interdisciplinary research, advancements in bioinformatics and computational tools. Major trends in the forecast period include advancements in data science and bioinformatics, genomic sequencing technologies, machine learning and ai in bioinformatics, drug discovery and development, personalized medicine and precision healthcare.

Government funding has been the major driver in the computational biology market. Governments across the globe are funding infrastructure and academic courses to improve the capabilities of computational biologics in R&D, educational institutions, and other sectors. The rapid growth in government funding is expected to boost the demand for computational biological solutions, as they are widely used in R&D, clinical research, and other development activities. For instance, in April 2023, according to National Cancer Institute (NCI), a US-based government agency, in the fiscal year 2021, the NCI had a total budget of $6. 4 billion, which included $195 million in funding from the CURES Act. This represented a 1. 6 percent increase, equivalent to $99. 3 million, compared to the preceding fiscal year. Therefore, government funding is driving the computational biology market growth.

The increasing demand for personalized medicine is expected to propel the growth of computational biology going forward. Personalized medicine, also known as precision medicine, is an approach to medical treatment and healthcare that takes into account individual variability in genes, environment, and lifestyle when developing treatment plans for patients. Personalized medicine relies on analyzing an individual's genetic data to tailor medical treatments. Computational biology plays a vital role in interpreting this genetic information, enabling the development of targeted therapies, optimizing treatment regimens, and predicting treatment outcomes. It helps stratify patients into specific subgroups, reduces healthcare costs, and aligns with regulatory and clinical guidelines. For instance, in 2022, according to the Personalized Medicine Coalition, a US-based professional membership organization, the Food and Drug Administration's Center for Drug Evaluation and Research (CDER) approved 37 new molecular entities (NMEs) in 2022. Out of the 35 therapeutic NMEs, approximately 34%, which amounts to 12 of them, are classified as personalized medicines by the Personalized Medicine Coalition (PMC). Therefore, the increasing demand for personalized medicine is driving the growth of the computational biology market.

Major companies operating in the computational biology market are developing new solutions for proteomics research to gain a competitive edge in the market. Proteomics research is a field of scientific study focused on the comprehensive analysis of proteins in a biological system. For instance, in May 2023, Biognosys AG, a Switzerland-based biotechnology company launched Spectronaut 18 and unveiled significant scientific and technological enhancements for its exclusive proteomics research software and offerings. Spectronaut 18 offers high throughput and efficiency in data-independent acquisition (DIA) proteomics analysis. The company's TrueDiscovery platform accelerates biomarker discovery in fields like oncology and neuroscience by providing unparalleled depth and sensitivity in proteomics. TrueTarget enables high-resolution drug target identification and deconvolution, and Biognosys' iRT Kit, recommended for real-time system suitability monitoring, is now supported in combination with Bruker ProteoScape software.

Major companies operating in the computational biology market are developing advanced biosimulation solutions to gain a competitive edge in the market. Biosimulation software refers to a category of computer programs and tools used in the field of computational biology and pharmacology to simulate and model biological systems and processes. For instance, in June 2022, Certara, a US-based software development company launched new versions of its Immunogenicity (IG), Immuno-oncology (IO), and Vaccine Simulators to enhance the predictability of novel biologic therapies in drug development. These simulators are built on quantitative systems pharmacology (QSP) and use computational modeling and experimental data to understand drug interactions with biological systems and disease processes. They assist in creating virtual patients, conducting computer-based trials, and predicting drug behavior in patients, streamlining the drug development process and minimizing risks. Certara's IG Simulator assesses immunogenicity in various biologic therapies, the IO Simulator optimizes cancer therapy combinations, and the Vaccine Simulator determines vaccine dosing strategies.

In March 2022, ZS Associates, a US-based provider of professional services acquired Intomics for an undisclosed amount. Through this acquisition, ZS Associates is focused on diversifying their business activities and offering its clients innovative solutions. Intomics is a Denmark-based provider of bioinformatics solutions and system biology.

Major companies operating in the computational biology market include Certara L. P, Chemical Computing Group Inc., Compugen Ltd., Genedata AG, Insilico Biotechnology AG, Dassault Systemes SE, Instem PLC, Rosa & Co. LLC, Simulation Plus Inc., Nimbus Discovery LLC, Rhenovia Pharma SAS, Leadscope Inc., DNAnexus, Altaris Capital Partner, Genialis Inc., Inari Agriculture Inc., BC Platforms, Ventus Therapeutics, Monte Rosa Therapeutics, Schrodinger Inc., Strand Life Sciences, Entos Pharmaceuticals, Numerate Inc., Insitro, Recursion Pharmaceuticals, Atomwise, Relay Therapeutics, Exscientia

North America was the largest region in the computational biology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the computational biology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the computational biology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.

The computational biology market includes revenues earned by entities by providing biological notions rigor and verifiability, as well as by offering a framework that connects diverse insights. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Computational Biology Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on computational biology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for computational biology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The computational biology market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Services: In-house; Contract
• 2) By Tools: Databases; Infrastructure (Hardware); Analysis Software and Services
• 3) By Application: Cellular and Biological Simulation; Drug Discovery and Disease Modelling; Clinical Trials
• 4) By End Users: Research; Pharmaceutical Industry; Commercial Applications
• Subsegments:
• 1) By In-house: Data Analysis; Software Development; Research And Development
• 2) By Contract: Outsourced Bioinformatics; Collaborative Research; Data Management Services
• Companies Mentioned: Certara L. P; Chemical Computing Group Inc.; Compugen Ltd.; Genedata AG; Insilico Biotechnology AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Computational Biology Market Characteristics

3. Computational Biology Market Trends And Strategies

4. Computational Biology Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Computational Biology Growth Analysis And Strategic Analysis Framework

• 5.1. Global Computational Biology PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Computational Biology Market Growth Rate Analysis
• 5.4. Global Computational Biology Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Computational Biology Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Computational Biology Total Addressable Market (TAM)

6. Computational Biology Market Segmentation

• 6.1. Global Computational Biology Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• In-house
• Contract
• 6.2. Global Computational Biology Market, Segmentation By Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Databases
• Infrastructure (Hardware)
• Analysis Software and Services
• 6.3. Global Computational Biology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cellular and Biological Simulation
• Drug Discovery and Disease Modelling
• Clinical Trials
• 6.4. Global Computational Biology Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Research
• Pharmaceutical Industry
• Commercial Applications
• 6.5. Global Computational Biology Market, Sub-Segmentation Of In-house, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Data Analysis
• Software Development
• Research And Development
• 6.6. Global Computational Biology Market, Sub-Segmentation Of Contract, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Outsourced Bioinformatics
• Collaborative Research
• Data Management Services

7. Computational Biology Market Regional And Country Analysis

• 7.1. Global Computational Biology Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Computational Biology Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Computational Biology Market

• 8.1. Asia-Pacific Computational Biology Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Computational Biology Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Computational Biology Market, Segmentation By Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Computational Biology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Computational Biology Market

• 9.1. China Computational Biology Market Overview
• 9.2. China Computational Biology Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Computational Biology Market, Segmentation By Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Computational Biology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Computational Biology Market

• 10.1. India Computational Biology Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Computational Biology Market, Segmentation By Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Computational Biology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Computational Biology Market

• 11.1. Japan Computational Biology Market Overview
• 11.2. Japan Computational Biology Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Computational Biology Market, Segmentation By Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Computational Biology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Computational Biology Market

• 12.1. Australia Computational Biology Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Computational Biology Market, Segmentation By Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Computational Biology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Computational Biology Market

• 13.1. Indonesia Computational Biology Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Computational Biology Market, Segmentation By Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Computational Biology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Computational Biology Market

• 14.1. South Korea Computational Biology Market Overview
• 14.2. South Korea Computational Biology Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Computational Biology Market, Segmentation By Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Computational Biology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Computational Biology Market

• 15.1. Western Europe Computational Biology Market Overview
• 15.2. Western Europe Computational Biology Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Computational Biology Market, Segmentation By Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Computational Biology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Computational Biology Market

• 16.1. UK Computational Biology Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Computational Biology Market, Segmentation By Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Computational Biology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Computational Biology Market

• 17.1. Germany Computational Biology Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Computational Biology Market, Segmentation By Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Computational Biology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Computational Biology Market

• 18.1. France Computational Biology Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Computational Biology Market, Segmentation By Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Computational Biology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Computational Biology Market

• 19.1. Italy Computational Biology Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Computational Biology Market, Segmentation By Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Computational Biology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Computational Biology Market

• 20.1. Spain Computational Biology Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Computational Biology Market, Segmentation By Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Computational Biology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Computational Biology Market

• 21.1. Eastern Europe Computational Biology Market Overview
• 21.2. Eastern Europe Computational Biology Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Computational Biology Market, Segmentation By Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Computational Biology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Computational Biology Market

• 22.1. Russia Computational Biology Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Computational Biology Market, Segmentation By Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Computational Biology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Computational Biology Market

• 23.1. North America Computational Biology Market Overview
• 23.2. North America Computational Biology Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Computational Biology Market, Segmentation By Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Computational Biology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Computational Biology Market

• 24.1. USA Computational Biology Market Overview
• 24.2. USA Computational Biology Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Computational Biology Market, Segmentation By Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Computational Biology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Computational Biology Market

• 25.1. Canada Computational Biology Market Overview
• 25.2. Canada Computational Biology Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Computational Biology Market, Segmentation By Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Computational Biology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Computational Biology Market

• 26.1. South America Computational Biology Market Overview
• 26.2. South America Computational Biology Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Computational Biology Market, Segmentation By Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Computational Biology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Computational Biology Market

• 27.1. Brazil Computational Biology Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Computational Biology Market, Segmentation By Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Computational Biology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Computational Biology Market

• 28.1. Middle East Computational Biology Market Overview
• 28.2. Middle East Computational Biology Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Computational Biology Market, Segmentation By Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Computational Biology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Computational Biology Market

• 29.1. Africa Computational Biology Market Overview
• 29.2. Africa Computational Biology Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Computational Biology Market, Segmentation By Tools, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Computational Biology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Computational Biology Market Competitive Landscape And Company Profiles

• 30.1. Computational Biology Market Competitive Landscape
• 30.2. Computational Biology Market Company Profiles
  • 30.2.1. Certara L. P Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Chemical Computing Group Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Compugen Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Genedata AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Insilico Biotechnology AG Overview, Products and Services, Strategy and Financial Analysis

31. Computational Biology Market Other Major And Innovative Companies

• 31.1. Dassault Systemes SE
• 31.2. Instem PLC
• 31.3. Rosa & Co. LLC
• 31.4. Simulation Plus Inc.
• 31.5. Nimbus Discovery LLC
• 31.6. Rhenovia Pharma SAS
• 31.7. Leadscope Inc.
• 31.8. DNAnexus
• 31.9. Altaris Capital Partner
• 31.10. Genialis Inc.
• 31.11. Inari Agriculture Inc.
• 31.12. BC Platforms
• 31.13. Ventus Therapeutics
• 31.14. Monte Rosa Therapeutics
• 31.15. Schrodinger Inc.

32. Global Computational Biology Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Computational Biology Market

34. Recent Developments In The Computational Biology Market

35. Computational Biology Market High Potential Countries, Segments and Strategies

• 35.1 Computational Biology Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Computational Biology Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Computational Biology Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer